Docusign targets 18% IAM ARR share in fiscal 2027 while expanding AI partnerships (NASDAQ:DOCU)March 18, 2026
Share Facebook Twitter LinkedIn Pinterest Email Krystal Biotech maintains Outperform rating, $168 stock price target